Medtronic has increased its dividend for 48 consecutive years, with a healthy payout that is expected to continue growing. The healthcare technology company raised its quarterly payment to $0.71 per share, yielding 2.9%. Medtronic generated $5.2 billion in free cash flow in 2025, covering its dividend outlay. The company’s strong balance sheet and growth profile make it a promising investment for those seeking a steadily rising dividend. Medtronic is on track to become a Dividend King, with potential for future success and shareholder returns.

Read more at Nasdaq: Which ‘Dividend Prince’ Will Become The Next King In 2 Years?